Table 1

Demographic and tumor characteristics of breast cancer cases and controls by cyclin D1 status among young women <45 years of age in New Jersey from 1990 to 1992

Cyclin D1+an (%)Cyclin D1bn (%)Controlscn (%)P
Age (yrs) at diagnosis38.91 (4.28)d38.83 (4.36)d37.75 (4.80)d0.003
 23–29 yr3 (2.44)10 (4.13)27 (5.84)0.21
 30–34 yr18 (14.63)35 (14.46)83 (17.97)
 35–39 yr36 (28.10)68 (28.10)147 (31.82)
 40–44 yr66 (53.31)129 (53.31)205 (44.37)
Stage at diagnosis
In situ15 (12.30)27 (11.34)0.62
 Local57 (46.72)124 (52.10)
 Regional/Distant50 (40.98)87 (36.55)
ER status0.01
 No test or unknown24 (19.51)30 (12.40)
 Positive69 (56.10)99 (40.91)
 Borderline12 (9.76)18 (7.44)
 Negative18 (14.63)95 (39.26)
Progesterone receptor status0.001
 No test or unknown25 (20.33)37 (15.29)
 Positive72 (58.54)109 (45.04)
 Borderline4 (3.25)13 (5.37)
 Negative22 (17.89)83 (34.30)
Race
 White108 (87.80)201 (83.06)382 (82.68)0.34
 Black8 (6.50)30 (12.40)48 (10.39)
 Asian and other7 (5.69)11 (4.55)32 (6.93)
Religion
 Protestant39 (31.71)77 (31.82)154 (33.33)0.52
 Jewish15 (12.20)21 (8.68)46 (9.96)
 Catholic65 (52.85)138 (57.02)238 (51.52)
 Other/None4 (3.25)6 (2.48)24 (5.19)
  • a N = 123.

  • b N = 242.

  • c N = 462.

  • d Mean (SD).